You just read:

CytRx Presents Interim Results from On-going Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial at ESMO 2016 Congress

News provided by

CytRx Corporation

10 Oct, 2016, 09:00 ET